Laboratory blood test history of SLE patients who received the final diagnosis of ANCA-associated vasculitis after SARS-CoV-2 infection
Laboratory test . | 10 July 2020 . | 5 November 2020 . | 11 January 2021 . | 5 March 2021 . |
---|---|---|---|---|
White blood cells, 109/L | 4.2 | 4.6 | 9.9 | 6.2 |
Haemoglobin, g/dl | 12.0 | 13.7 | 8.8 | 11.9 |
Platelets, 109/L | 237 | 235 | 307 | 187 |
ESR, mm/h | 49 | 19 | 124 | 12 |
CRP, mg/dL | 0.3 | 0.1 | 1.76 | 0.11 |
C3 complement, mg/dL | – | 94 | 118 | 97 |
C4 complement, mg/dL | – | 9 | 17 | 8 |
TSH, mIU/L | 13.7 | – | 1.06 | – |
Creatinine, mg/dL | 1.09 | 0.97 | 2.83 | 1.43 |
ANA | 1/640a | – | 1/160 | 1/160 |
aPL | – | Negative | Negative | – |
Anti-dsDNA antibody | – | Negative | – | – |
Urine sediment | Red blood cells | Normal | >100 urinary red blood cells/hpf, erythrocyte casts | 20 urinary red blood cells/hpf, no erythrocyte casts |
Urine protein | 0.3 mg/dl | – | 2128 mg/24h | 1088 mg/24 h |
Anti-GBM antibody | – | – | Negative | – |
MPO-ANCA | – | – | Positive | Negative |
Laboratory test . | 10 July 2020 . | 5 November 2020 . | 11 January 2021 . | 5 March 2021 . |
---|---|---|---|---|
White blood cells, 109/L | 4.2 | 4.6 | 9.9 | 6.2 |
Haemoglobin, g/dl | 12.0 | 13.7 | 8.8 | 11.9 |
Platelets, 109/L | 237 | 235 | 307 | 187 |
ESR, mm/h | 49 | 19 | 124 | 12 |
CRP, mg/dL | 0.3 | 0.1 | 1.76 | 0.11 |
C3 complement, mg/dL | – | 94 | 118 | 97 |
C4 complement, mg/dL | – | 9 | 17 | 8 |
TSH, mIU/L | 13.7 | – | 1.06 | – |
Creatinine, mg/dL | 1.09 | 0.97 | 2.83 | 1.43 |
ANA | 1/640a | – | 1/160 | 1/160 |
aPL | – | Negative | Negative | – |
Anti-dsDNA antibody | – | Negative | – | – |
Urine sediment | Red blood cells | Normal | >100 urinary red blood cells/hpf, erythrocyte casts | 20 urinary red blood cells/hpf, no erythrocyte casts |
Urine protein | 0.3 mg/dl | – | 2128 mg/24h | 1088 mg/24 h |
Anti-GBM antibody | – | – | Negative | – |
MPO-ANCA | – | – | Positive | Negative |
aNuclear pattern.
TSH: thyroid-stimulating hormone; GBM: glomerular basement membrane; hpf: high-power field.
Laboratory blood test history of SLE patients who received the final diagnosis of ANCA-associated vasculitis after SARS-CoV-2 infection
Laboratory test . | 10 July 2020 . | 5 November 2020 . | 11 January 2021 . | 5 March 2021 . |
---|---|---|---|---|
White blood cells, 109/L | 4.2 | 4.6 | 9.9 | 6.2 |
Haemoglobin, g/dl | 12.0 | 13.7 | 8.8 | 11.9 |
Platelets, 109/L | 237 | 235 | 307 | 187 |
ESR, mm/h | 49 | 19 | 124 | 12 |
CRP, mg/dL | 0.3 | 0.1 | 1.76 | 0.11 |
C3 complement, mg/dL | – | 94 | 118 | 97 |
C4 complement, mg/dL | – | 9 | 17 | 8 |
TSH, mIU/L | 13.7 | – | 1.06 | – |
Creatinine, mg/dL | 1.09 | 0.97 | 2.83 | 1.43 |
ANA | 1/640a | – | 1/160 | 1/160 |
aPL | – | Negative | Negative | – |
Anti-dsDNA antibody | – | Negative | – | – |
Urine sediment | Red blood cells | Normal | >100 urinary red blood cells/hpf, erythrocyte casts | 20 urinary red blood cells/hpf, no erythrocyte casts |
Urine protein | 0.3 mg/dl | – | 2128 mg/24h | 1088 mg/24 h |
Anti-GBM antibody | – | – | Negative | – |
MPO-ANCA | – | – | Positive | Negative |
Laboratory test . | 10 July 2020 . | 5 November 2020 . | 11 January 2021 . | 5 March 2021 . |
---|---|---|---|---|
White blood cells, 109/L | 4.2 | 4.6 | 9.9 | 6.2 |
Haemoglobin, g/dl | 12.0 | 13.7 | 8.8 | 11.9 |
Platelets, 109/L | 237 | 235 | 307 | 187 |
ESR, mm/h | 49 | 19 | 124 | 12 |
CRP, mg/dL | 0.3 | 0.1 | 1.76 | 0.11 |
C3 complement, mg/dL | – | 94 | 118 | 97 |
C4 complement, mg/dL | – | 9 | 17 | 8 |
TSH, mIU/L | 13.7 | – | 1.06 | – |
Creatinine, mg/dL | 1.09 | 0.97 | 2.83 | 1.43 |
ANA | 1/640a | – | 1/160 | 1/160 |
aPL | – | Negative | Negative | – |
Anti-dsDNA antibody | – | Negative | – | – |
Urine sediment | Red blood cells | Normal | >100 urinary red blood cells/hpf, erythrocyte casts | 20 urinary red blood cells/hpf, no erythrocyte casts |
Urine protein | 0.3 mg/dl | – | 2128 mg/24h | 1088 mg/24 h |
Anti-GBM antibody | – | – | Negative | – |
MPO-ANCA | – | – | Positive | Negative |
aNuclear pattern.
TSH: thyroid-stimulating hormone; GBM: glomerular basement membrane; hpf: high-power field.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.